TCIM
MRTX
TIAA CREF Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $15.4M | Sell |
210,115
-60,791
| -22% | -$4.46M | 0.01% | 824 |
|
|
2018
Q4 | $11.5M | Buy |
270,906
+215,077
| +385% | +$9.12M | 0.01% | 888 |
|
|
2018
Q3 | $2.63M | Sell |
55,829
-605
| -1% | -$28.5K | ﹤0.01% | 1977 |
|
|
2018
Q2 | $2.78M | Buy |
+56,434
| New | +$2.78M | ﹤0.01% | 1994 |
|
|
2017
Q2 | – | Sell |
-51,202
| Closed | -$266K | – | 3193 |
|
|
2017
Q1 | $266K | Sell |
51,202
-8,839
| -15% | -$45.9K | ﹤0.01% | 2948 |
|
|
2016
Q4 | $285K | Sell |
60,041
-19,106
| -24% | -$90.7K | ﹤0.01% | 2986 |
|
|
2016
Q3 | $523 | Buy |
79,147
+28,775
| +57% | +$190 | ﹤0.01% | 2829 |
|
|
2016
Q2 | $275K | Buy |
50,372
+14,977
| +42% | +$81.8K | ﹤0.01% | 3049 |
|
|
2016
Q1 | $757K | Hold |
35,395
| – | – | ﹤0.01% | 2617 |
|
|
2015
Q4 | $1.12M | Buy |
35,395
+2,666
| +8% | +$84.2K | ﹤0.01% | 2512 |
|
|
2015
Q3 | $1.13M | Sell |
32,729
-903
| -3% | -$31.1K | ﹤0.01% | 2503 |
|
|
2015
Q2 | $1.06M | Buy |
33,632
+6,323
| +23% | +$199K | ﹤0.01% | 2669 |
|
|
2015
Q1 | $801K | Hold |
27,309
| – | – | ﹤0.01% | 2737 |
|
|
2014
Q4 | $506K | Sell |
27,309
-321
| -1% | -$5.95K | ﹤0.01% | 2959 |
|
|
2014
Q3 | $484K | Hold |
27,630
| – | – | ﹤0.01% | 2979 |
|
|
2014
Q2 | $553K | Buy |
+27,630
| New | +$553K | ﹤0.01% | 2989 |
|